Scott Thielman Talks the Rise of Prescription Digital Therapeutics (PDTs) at BIOMEDevice

CTO Scott Thielman heads down to San Jose December 8-9 to talk about advancing the digital health and personal diagnostics development sector at the Silicon Valley BIOMEDevice event.

Panel: Is there an App for That? The Rise of Prescription Digital Therapeutics (PDTs)

On the final day of the conference, December 9, Scott will be hosting a panel titled: Is there an App for That? The Rise of Prescription Digital Therapeutics (PDTs).

Details:

Date: Thursday, December 9

Time: 2:45 - 3:45 PM PST

Location: Center Stage

Panel Guests: Gordan Kass of Pear Therapeutics, Jessica Lake PhD of Limbix, Mike Rosenbluth of Swing Therapeutics, and Kristin Wynholds of Better Therapeutics.

Summary

A growing number of companies are latching onto the digital therapeutics label. The main difference between digital therapeutics and other sectors within digital health is that digital therapeutics are generally expected to be evidence-based, regulated technologies designed to trigger changes in patient behavior. Digital health products are not necessarily evidence-based or regulated. Clear FDA guidance around software-based therapeutics and defined paths for reimbursement are providing for better outcomes for patients, and smarter engagement and tracking tools for clinicians. Come join leading industry experts as they discuss:

• Industry trends in novel target therapeutic approaches for PDTs

• The use of special-purpose acquisition (SPAC) money by investors for raising money for digital therapeutics

• Overcoming common product development challenges

• Proving behavior change through evidence-based interventions

Schedule a meeting with us!

Are you going to be in the area? If so, we would love to connect! Shoot us an email at info@productcreationstudio.com to set up a meeting. We’d love to see you there!